John L. Dornhoffer profile photo

John L. Dornhoffer

High Impact

Department Chairperson

University of Arkansas for Medical Sciences

faculty

Department Chairs, College of Medicine

35 h-index 176 pubs 4,131 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

John L. Dornhoffer's research focuses on otologic surgery and patient outcomes, with a particular emphasis on ossiculoplasty and cochlear implantation. He has investigated factors influencing hearing outcomes in ossiculoplasty, including the impact of surgical techniques and the ear environment risk. His work also examines patient barriers to cochlear implantation and the displacement of cochlear implants following head trauma.

Dornhoffer has explored the use of novel biomaterials in otologic procedures, such as porcine small intestinal submucosal graft. Additionally, his research includes an analysis of adverse events associated with Eustachian tube balloon dilation and its potential application in pediatric patients with refractory dysfunction. He also studies the association between electroencephalogram (EEG) activity and tinnitus awareness after transcranial magnetic stimulation (rTMS).

With an h-index of 35, 176 total publications, and over 4,100 citations, Dornhoffer is recognized as a highly cited researcher. He collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Robert Saadi, Andrew Mangan, Olivia Speed, and Alexa N. Pearce, with whom he has co-authored multiple publications.

Metrics

  • h-index: 35
  • Publications: 176
  • Citations: 4,131

Selected Publications

  • Cochlear Implantation Outcomes in Paget’s Disease of the Bone: A Systematic Review (2026) DOI
  • What Is the Optimal Timing for Cochlear Implantation in a Post‐Meningitic Infant With Sensorineural Hearing Loss? (2026) DOI
  • Computerized Dynamic Posturography (2026) DOI
  • Revision Flap Coverage Following Primary Cochlear Implant Flap Failure: A Systematic Review (2025) DOI
  • Cochlear implantation in patients with keratitis-ichthyosis-deafness syndrome: A systematic review (2025) DOI
  • Impact of Modifiable Surgical Factors on Ossiculoplasty Outcomes After Controlling for Ear Environment Risk: A Multi-Institutional Study (2025) DOI
  • Cochlear implantation in cochlear nerve deficiency: A systematic review (2025) DOI
  • A Systematic Review of Case Reports of Spontaneous Retropharyngeal Hematoma (2025) DOI
  • Slag Injuries to the Tympanic Membrane and Middle Ear—A Systematic Review (2025) DOI
  • A Multi‐Center Study of Ossiculoplasty Hearing Outcomes and a Grading Scale of Ear Environment Risk (2024) DOI
  • Racial and ethnic disparities in Meniere's disease clinical trials: A systematic review (2024) DOI
  • Auditory brainstem implants: an analysis of adverse events in the MAUDE database (2024) DOI
  • Exploring the Prevalence of Psychiatric Disorders in Otosclerosis Patients: A Systematic Review (2024) DOI
  • Diagnosis and management of facial nerve palsy secondary to granulomatosis with polyangiitis – A systematic review (2023) DOI
  • Eustachian Tube Balloon Dilation: A Comprehensive Analysis of Adverse Events (2023) DOI

Grants & Funding

  • Pharmacological Countermeasures for Space Motion Sickness National Space Biomedical Research Institute Principal Investigator
  • ““RoboHear™ device: advanced haptic technology that allows deaf to understand speech.” NIH/National Institutes of Health - Pass Through: Fauxsee Innovations LLC Principal Investigator
  • Center for Translational Neuroscience NIH Co-Investigator
  • Moving AAO-HNSF Clinical Practice Guidelines into Practice: The Sudden Hearing Loss Guideline (CHEER Site 400A) American Academy of Otolaryngology - Pass Through: Duke University Principal Investigator
  • Moving AAO-HNSF Clinical Practice Guidelines into Practice: The Sudden Hearing Loss Guideline (CHEER Site 400A) American Academy of Otolaryngology - Pass Through: Duke University Principal Investigator
  • A Phase 1/2, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of ASP0598Otic Solution Following Topical application into the Ear in Subjects with Chronic Tympanic Membrane Perforation (CTMP) Astellas Pharma US, Inc. Principal Investigator
  • ““RoboHear™ device: advanced haptic technology that allows deaf to understand speech.” NIH/Nat. Inst. on Deafness & Other Communication Disorders - Pass Through: Fauxsee Innovations LLC Principal Investigator
  • A Phase 1/2, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of ASP0598Otic Solution Following Topical application into the Ear in Subjects with Chronic Tympanic Membrane Perforation (CTMP) Astellas Pharma US, Inc. Principal Investigator

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics